About 33 results found for searched term "Dipeptidyl Peptidase" (0.113 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M7863 | Diprotin A (Ile-Pro-Ile) | Dipeptidyl Peptidase |
| Dipeptidyl peptidase IV inhibitor | ||
| Diprotin A (Ile-Pro-Ile) is an inhibitor of dipeptidyl peptidase IV. | ||
| M55024 | Recombinant Human DPP4/CD26 (HEK293, C-6His) | Cytokines and Growth Factors |
| Dipeptidyl Peptidase 4; DPP IV; ADCP-2 | ||
| DPP4/CD26 is a signal-anchor for type II membrane protein that belongs to the peptidase S9B family. DPP4/CD26 acts as a positive regulator of T-cell coactivation, by binding at least ADA, CAV1, IGF2R, and PTPRC. It’s binding to CAV1 and CARD11 induces T-cell proliferation and NF-kappa-B activation in a T-cell receptor/CD3-dependent manner. | ||
| M55375 | Recombinant Human CD143/ACE (E. coli, N-GST) | Cytokines and Growth Factors |
| Dipeptidyl carboxypeptidase I; DCP1 | ||
| CD143/ACE Protein is a recombinant human Angiotensin I-converting enzyme (ACE, CD143) which hydrolyzes small peptides such as angiotensin I, bradykinin, substance P, LH-RH and several others and thus plays a key role in blood pressure regulation and vascular remodeling. ACE plays a crucial role in blood pressure regulation, vascular remodeling, and immunity. | ||
| M55549 | Recombinant Mouse DPP-4/CD26 Protein (HEK293, N-hFc) | Cytokines and Growth Factors |
| Dipeptidyl Peptidase 4; DPP IV | ||
| Dipeptidyl peptidase-4 (DPP4, CD26) is a serine exopeptidase belonging to the S9B protein family. The enzyme is a type II transmembrane glycoprotein, expressed on the surface of many cell types. It is also present in serum and other body fluids in a truncated form (sCD26/DPPIV). | ||
| M1967 | Sitagliptin phosphate monohydrate | Dipeptidyl Peptidase |
| MK-0431, Januvia | ||
| Sitagliptin phosphate (MK-0431) is a potent inhibitor of dipeptidyl peptidase-4 (DPP-4) with IC50 of 19 nM. | ||
| M3119 | Vildagliptin | Dipeptidyl Peptidase |
| LAF237; NVP-LAF 237 | ||
| Vildagliptin (LAF237) is a potent, stable, selective dipeptidyl peptidase IV (DPP-IV) inhibitor with an IC50 of 3.5 nM in human Caco-2 cells. Vildagliptin possesses excellent oral bioavailability and potent antihyperglycemic activity. | ||
| M3435 | Saxagliptin | Dipeptidyl Peptidase |
| BMS-477118 | ||
| Saxagliptin (BMS-477118) is a potent, selective, reversible, competitive and orally active inhibitor of dipeptidyl peptidase 4 (DPP-4) (Ki = 0.6-1.3 nM). Saxagliptin can be used in type 2 diabetes studies. | ||
| M1333 | Talabostat mesylate | Dipeptidyl Peptidase |
| BXCL701 mesylate; Val-boroPro mesylate; PT100 mesylate | ||
| Talabostat mesylate (Val-boroPro mesylate; PT100 mesylate) is an orally active and nonselective dipeptidyl peptidase IV (DPP-IV) inhibitor (IC50 < 4 nM; Ki = 0.18 nM) and the first clinical inhibitor of fibroblast activation protein (FAP) (IC50 = 560 nM). | ||
| M5994 | Teneligliptin hydrobromide hydrate | Dipeptidyl Peptidase |
| MP-513 hydrobromide hydrate | ||
| Teneligliptin (MP-513) hydrobromide hydrate is a novel, potent, and long-lasting dipeptidyl peptidase-4 inhibitor; competitively inhibited human plasma, rat plasma, and human recombinant DPP-4 in vitro, with IC50 values of approximately 1 nM. | ||
| M5995 | Teneligliptin hydrobromide | Dipeptidyl Peptidase |
| MP-513 hydrobromide | ||
| Teneligliptin hydrobromide is a novel, potent, and long-lasting dipeptidyl peptidase-4 inhibitor; competitively inhibited human plasma, rat plasma, and human recombinant DPP-4 in vitro, with IC50 values of approximately 1 nM. | ||
| M7143 | PK 44 phosphate | Others |
| PK 44 phosphate is a potent and selective dipeptidyl peptidase IV (DPP-IV) inhibitor. | ||
| M7444 | UAMC 00039 dihydrochloride | Others |
| UAMC 00039 dihydrochloride is a dipeptidyl peptidase II (DPP-II) inhibitor. | ||
| M8464 | NDMC101 | Others |
| NDMC101 (HS Cm) is a potent dipeptidyl peptidase-IV (DPPIV) inhibitor in T cells with low cytotoxicity. | ||
| M8882 | Trelagliptin succinate | Dipeptidyl Peptidase |
| SYR472 succinate | ||
| Trelagliptin(SYR-472) succinate is a long acting dipeptidyl peptidase-4 (DPP-4) inhibitor that is being developed for the treatment of type 2 diabetes (T2D). | ||
| M9575 | NVP-DPP-728 dihydrochloride | Dipeptidyl Peptidase |
| NVP-728 2HCl | ||
| NVP-DPP-728 dihydrochloride is a potent and selective dipeptidyl peptidase IV inhibitor. | ||
| M9609 | SP-13786 | FAP |
| UAMC-1110 | ||
| SP-13786 (UAMC-1110) is a novel potent and selective inhibitor of fibroblast activation protein (fap), displaying low nanomolar inhibitory potency and high selectivity against the related dipeptidyl peptidases (dpps) dppiv, dpp9, dppii, and prolyl oligopeptidase (prep). | ||
| M14317 | Brensocatib | Dipeptidyl Peptidase |
| AZD7986; INS 1007 | ||
| Brensocatib (AZD7986) is a first-in-class, oral dipeptidyl peptidase 1 (DPP1) inhibitor with pIC50s of 6.85, 7.6, 7.7, 7.8, and 7.8 in human, mouse, rat, dog and rabbit, respectively. | ||
| M20841 | Gemigliptin | Dipeptidyl Peptidase |
| Zemiglo, LC15-0444 | ||
| Gemigliptin (Zemiglo, LC15-0444) is a potent, selective and long-acting dipeptidyl peptidase 4 (DPP 4) inhibitor with a Ki of 7.25 nM. Gemigliptin shows at least >23,000-fold selectivity for DPP-4 over various proteases and peptidases, including DPP-8, DPP-9, and fibroblast activation protein (FAP)-α. | ||
| M21422 | ICeD-2 | Others |
| ICeD-2 is a dipeptidyl peptidase 9 (DPP9) inhibitor that is being developed for HIV-1 infection. | ||
| M28160 | Fotagliptin | Dipeptidyl Peptidase |
| Fotagliptin is a Dipeptidyl Peptidase IV (DPP-4) inhibitor (IC50=2.27 nM). Fotagliptin displays great security in rat and dog. Fotagliptin can be used for Type 2 diabetes mellitus research. | ||
| M28256 | P32/98 | Dipeptidyl Peptidase |
| P32/98 a potent inhibitor of dipeptidyl peptidase IV with a Ki value of 130 nM. P32/98 improves glucose tolerance, insulin sensitivity and β-cell responsiveness in fatty Zucker rat model. | ||
| M28341 | Fotagliptin benzoate | Dipeptidyl Peptidase |
| Fotagliptin benzoate is a Dipeptidyl Peptidase IV (DPP-4) inhibitor (IC50=2.27 nM). Fotagliptin benzoate displays great security in rat and dog. Fotagliptin benzoate can be used for Type 2 diabetes mellitus research. | ||
| M28540 | Talabostat | Dipeptidyl Peptidase |
| Val-boroPro; PT100 | ||
| Talabostat (Val-boroPro; PT100) is an orally active and nonselective dipeptidyl peptidase IV (DPP-IV) inhibitor (IC50 < 4 nM; Ki = 0.18 nM) and the first clinical inhibitor of fibroblast activation protein (FAP) (IC50 = 560 nM), inhibits DPP8/9 (IC50 = 4/11 nM; Ki = 1.5/0.76 nM), quiescent cell proline dipeptidase (QPP) (IC50 = 310 nM), DPP2, and some other DASH family enzymes. Antineoplastic and hematopoiesis- stimulating activities. | ||
| M29686 | P32/98 hemifumarate | Dipeptidyl Peptidase |
| P32/98 hemifumarateis a potent inhibitor of dipeptidyl peptidase IV with a Ki value of 130 nM. P32/98 hemifumarate improves glucose tolerance, insulin sensitivity and β-cell responsiveness in fatty Zucker rat model. | ||
| M29807 | GLP-2(3-33) | GLP Receptor |
| GLP-2(3-33), generated naturally by dipeptidylpeptidase IV (DPPIV), acts as a partial agonist on GLP-2 receptor (EC50=5.8 nM). | ||
| M30521 | Saxagliptin hydrochloride | Dipeptidyl Peptidase |
| BMS-477118 hydrochloride | ||
| Saxagliptin hydrochloride (BMS-477118 hydrochloride) is a potent, selective, reversible, competitive and orally active dipeptidyl peptidase-4 (DPP-4) (Ki = 0.6-1.3 nM) inhibitor. Saxagliptin hydrochloride has the peotential for type 2 diabetes mellitus research. | ||
| M30759 | Gosogliptin | Dipeptidyl Peptidase |
| PF-00734200; PF-734200 | ||
| Gosogliptin is a potent and selective inhibitor of dipeptidyl peptidase-IV (DPP-IV). | ||
| M31162 | Angiotensin Converting Enzyme (from porcine kidney) | Enzymes & Coenzymes |
| ACE; Carboxypeptidase,dipeptidyl, A | ||
| The angiotensin-converting enzyme (ACE) is a dipeptidyl-carboxypeptidase which exists in somatic and testicular isoforms with zinc binding motif HEXXH in their active site. ACE regulates blood pressure through renin-angiotensin system. | ||
| M31218 | Neuropeptide Y (3-36) (human, rat) | Neuropeptide Receptor |
| Neuropeptide Y (3-36) (human, rat), a neuropeptide Y (NPY) metabolite formed from dipeptidyl peptidase-4 (DPP4), is a selective Y2 receptor agonist. Neuropeptide Y (3-36) (human, rat) is a NPY metabolite formed from dipeptidyl peptidase-4 (DPP4). Neuropeptide Y (3-36) (human, rat) decreases release of norepinephrine via the Y2 receptor. | ||
| M39063 | 16-Hydroxycleroda-3,13-dien-15,16-olide | Dipeptidyl Peptidase |
| 16-Hydroxycleroda-3,13-dien-15,16-olide is a potent serine protease dipeptidyl peptidase 4 (DPP-4) inhibitor. 16-Hydroxycleroda-3,13-dien-15,16-olide down-regulates LPS-induced ERK phosphorylation in myocyte but blocks GLP-1 induced PKA expression. | ||
| M39064 | Saikogenin A | Dipeptidyl Peptidase |
| Saikogenin A, extracted from a Chinese herbal plant called Tsai-Fu, is a dipeptidyl peptidase-IV (DPP-IV) inhibitor. | ||
| M42328 | γ-Glu-Tyr | Dipeptidyl Peptidase |
| γ-Glu-Tyr, a competitive inhibitor of dipeptidyl peptidase-IV (DPP-IV) (IC50=6.77 mM), is a potentially functional component of the type 2 diabetes diet. | ||
| M42329 | Lys-Ala-pNA | Dipeptidyl Peptidase |
| Lys-Ala-pNA is hydrolytic substrate the of dipeptidyl peptidase (DPP) II with Km of 0.42 mM. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
